Key drivers for each region include: North America, driven by investments in research and development, policies supporting the use of Alamar Blue, and a mature ecosystem; Europe, driven by demographics, with an aging population driving demand for healthcare services, and infrastructure, with well-established research institutions; Asia Pacific, driven by adoption of Alamar Blue in emerging economies, policies supporting the use of Alamar Blue, and investments in research and development; Latin America, driven by increasing adoption of Alamar Blue, investments in pharmaceutical and biotechnology industries, and ecosystem maturity; and Middle East & Africa, driven by investments in research and development, policies supporting the use of Alamar Blue, and demographics, with a growing population driving demand for healthcare services.